Triamcinolone acetonide - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for triamcinolone acetonide and what is the scope of freedom to operate?
Triamcinolone acetonide
is the generic ingredient in twenty-seven branded drugs marketed by Abbvie, Chattem Sanofi, Astellas, Ivax Pharms, Delcor Asset Corp, Teva, Solvay, Actavis Mid Atlantic, Alkem Labs Ltd, Alpharma Us Pharms, Ambix, Chartwell Rx, Cosette, Encube, Fougera Pharms, Glenmark Pharms Ltd, Macleods Pharms Ltd, Micro Labs, Morton Grove, Mylan, Padagis Us, Pharmaderm, Pharmafair, Strides Pharma, Taro, Topiderm, Crown Labs, Savage Labs, Pacira Pharms Inc, Apothecon, Amneal, Eugia Pharma, Long Grove Pharms, Mylan Labs Ltd, Parnell, Sandoz, Teva Pharms Usa, Watson Labs, Allergan, Harrow Eye, Epic Pharma Llc, Pai Holdings Pharm, Quagen, Wockhardt Bio Ag, Aurobindo Pharma Ltd, Cintex Svcs, Glenmark Pharms, Padagis Israel, Cmp Pharma Inc, Akorn, Lyne, Lupin Atlantis, Sanofi Aventis Us, Apotex, Perrigo Pharma Intl, Sun Pharm Inds Inc, Rising, Saptalis Pharms, and Bausch And Lomb Inc, and is included in one hundred and thirty-nine NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.Triamcinolone acetonide has one hundred and fifty-seven patent family members in twenty-nine countries.
There are twenty-six drug master file entries for triamcinolone acetonide. Sixty-nine suppliers are listed for this compound.
Summary for triamcinolone acetonide
International Patents: | 157 |
US Patents: | 7 |
Tradenames: | 27 |
Applicants: | 59 |
NDAs: | 139 |
Drug Master File Entries: | 26 |
Finished Product Suppliers / Packagers: | 69 |
Raw Ingredient (Bulk) Api Vendors: | 80 |
Clinical Trials: | 255 |
Patent Applications: | 7,044 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for triamcinolone acetonide |
Drug Sales Revenues: | Drug sales revenues for triamcinolone acetonide |
What excipients (inactive ingredients) are in triamcinolone acetonide? | triamcinolone acetonide excipients list |
DailyMed Link: | triamcinolone acetonide at DailyMed |
Recent Clinical Trials for triamcinolone acetonide
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Gadjah Mada University | Phase 1/Phase 2 |
Innovaderm Research Inc. | Phase 4 |
Centre hospitalier de l'Université de Montréal (CHUM) | Phase 4 |
Pharmacology for triamcinolone acetonide
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for triamcinolone acetonide
Anatomical Therapeutic Chemical (ATC) Classes for triamcinolone acetonide
US Patents and Regulatory Information for triamcinolone acetonide
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Topiderm | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | CREAM;TOPICAL | 089275-001 | Feb 21, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Padagis Us | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | CREAM;TOPICAL | 086413-001 | Approved Prior to Jan 1, 1982 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Perrigo Pharma Intl | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | SPRAY, METERED;NASAL | 078104-002 | Nov 14, 2014 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Crown Labs | TRIDERM | triamcinolone acetonide | CREAM;TOPICAL | 088042-001 | Mar 19, 1984 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Chartwell Rx | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | CREAM;TOPICAL | 208763-002 | Feb 1, 2017 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Harrow Eye | TRIESENCE | triamcinolone acetonide | INJECTABLE;INTRAVITREAL | 022048-001 | Nov 29, 2007 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Glenmark Pharms Ltd | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | OINTMENT;TOPICAL | 206379-001 | Jul 22, 2016 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for triamcinolone acetonide
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chattem Sanofi | NASACORT ALLERGY 24 HOUR | triamcinolone acetonide | SPRAY, METERED;NASAL | 020468-002 | Oct 11, 2013 | ⤷ Try a Trial | ⤷ Try a Trial |
Chattem Sanofi | NASACORT | triamcinolone acetonide | AEROSOL, METERED;NASAL | 019798-001 | Jul 11, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
Delcor Asset Corp | KENALOG-H | triamcinolone acetonide | CREAM;TOPICAL | 086240-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | AZMACORT | triamcinolone acetonide | AEROSOL, METERED;INHALATION | 018117-001 | Apr 23, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Chattem Sanofi | NASACORT ALLERGY 24 HOUR | triamcinolone acetonide | SPRAY, METERED;NASAL | 020468-002 | Oct 11, 2013 | ⤷ Try a Trial | ⤷ Try a Trial |
Chattem Sanofi | NASACORT ALLERGY 24 HOUR | triamcinolone acetonide | SPRAY, METERED;NASAL | 020468-002 | Oct 11, 2013 | ⤷ Try a Trial | ⤷ Try a Trial |
Harrow Eye | TRIESENCE | triamcinolone acetonide | INJECTABLE;INTRAVITREAL | 022048-001 | Nov 29, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for triamcinolone acetonide
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 2015230874 | METHODS AND DEVICES FOR DRUG DELIVERY TO OCULAR TISSUE USING MICRONEEDLE | ⤷ Try a Trial |
Canada | 2890471 | PROCEDES ET DISPOSITIFS POUR LE TRAITEMENT DE MALADIES OCULAIRES CHEZ DES SUJETS HUMAINS (METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS) | ⤷ Try a Trial |
China | 102971030 | Methods and devices for drug delivery to ocular tissue using microneedle | ⤷ Try a Trial |
Taiwan | I468165 | ⤷ Try a Trial | |
South Korea | 20160005735 | 안구용 주사를 위한 장치 및 방법 (APPARATUS AND METHODS FOR OCULAR INJECTION) | ⤷ Try a Trial |
China | 116327482 | 用于眼部注射的设备和方法 (Apparatus and method for ocular injection) | ⤷ Try a Trial |
Mexico | 2013001433 | CORTICOSTEROIDES PARA EL TRATAMIENTO DE DOLOR DE ARTICULACIONES. (CORTICOSTEROIDS FOR THE TREATMENT OF JOINT PAIN.) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.